We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fetal Monitor Safeguards High-Risk Pregnancies

By HospiMedica staff writers
Posted on 14 May 2007
A new fetal monitor, the size of a mobile phone, helps expectant mothers check on their baby's heart beat without having to go into hospital and be attached to a machine.

The Monica AN24 is a small, wearable, battery-powered fetal/maternal electrophysiologic monitor, which weighs less than 100 g. More...
The monitor, developed by researchers at the University of Nottingham (UK), is designed for extensive periods of non-intrusive passive monitoring outside of the hospital setting, offering an alternative to current obstetric practice. The device will also be useful in monitoring high-risk pregnancies.

The highly sensitive monitor can gauge the heart rates of mother and fetus, as well as fetal position. The monitor converts the electrical signals from the maternal abdomen into a digital format and processes the data to extract clinically relevant information, such as the fetal heart rate (FHR), maternal heart rate (MHR), and other parameters during pregnancy. A detachable lead is connected to five disposable electrodes placed on the maternal abdomen, in a configuration designed to support the correct placement of the electrodes; little or no skill is needed to position the electrodes and commence monitoring. The resulting data can be also be transmitted by wireless technology to the nearest personal computer (PC).

"The device will be especially helpful in monitoring fetuses whose mothers suffer from medical conditions such as diabetes, autoimmune conditions such as systemic lupus erythematosus and Sjogren's syndrome, and obstetric cholestasis,” said one of the developers, Dr. Margaret Ramsay of the School of Human Development. "For all these fetuses, the more we can monitor them, the greater the chance of us detecting that they are running into difficulties before it is too late to help them.”

The technology developed at the university was spun out to create Monica Healthcare (Nottingham, UK). The monitor has passed all European Union (EU) regulatory safety standards and is currently undergoing clinical trials.


Related Links:
University of Nottingham
Monica Healthcare

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.